Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
68.04
-3.14 (-4.41%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Inspire Medical Systems Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 898.74 | 911.98 | 802.8 | 624.8 | 407.86 | 233.39 |
Revenue Growth | 4.35% | 13.60% | 28.49% | 53.19% | 74.75% | 102.28% |
Gross Profit Gross Profit Growth | 774.11 | 778.76 | 679.82 | 528.22 | 341.74 | 200.12 |
Operating Income Operating Income Growth | 54.12 | 50.95 | 36.08 | -40.27 | -47.59 | -39.85 |
Net Income Net Income Growth | 135.04 | 145.42 | 53.51 | -21.15 | -44.88 | -42.04 |
Earnings Per Share EPS Growth | 4.61 | 4.89 | 1.75 | -0.72 | -1.60 | -1.54 |
EPS Growth | 164.44% | 179.43% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 854.24 | 872.09 | 771.04 | 606.18 | 394.83 | 220.98 |
All Other Countries All Other Countries Growth | 44.51 | 39.9 | 31.76 | 18.62 | 13.02 | 12.42 |
Revenue (Total) Revenue (Total) Growth | 898.74 | 911.98 | 802.8 | 624.8 | 407.86 | 233.39 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 320.68 | 308.27 | 445.55 | 460.38 | 451.41 | 214.47 |
Total Debt Total Debt Growth | 29.09 | 32.16 | 31.79 | 24.85 | 8.87 | 34.1 |
Net Cash (Debt) Net Cash Growth | 291.59 | 276.11 | 413.75 | 435.53 | 442.54 | 180.37 |
Net Cash Growth | 8.87% | -33.27% | -5.00% | -1.58% | 145.35% | -11.46% |
Net Cash Per Share Net Cash Per Share Growth | 9.94 | 9.28 | 13.55 | 14.86 | 15.76 | 6.62 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 157.07 | 116.98 | 130.25 | 24.65 | 11.57 | -20.12 |
Capital Expenditures CapEx Growth | -39.98 | -38.5 | -39.12 | -23.63 | -9.1 | -4.67 |
Free Cash Flow Free Cash Flow Growth | 117.09 | 78.48 | 91.12 | 1.02 | 2.47 | -24.79 |
Free Cash Flow Growth | 37.74% | -13.88% | 8798.73% | -58.59% | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 86.13% | 85.39% | 84.68% | 84.54% | 83.79% | 85.74% |
Operating Margin | 6.02% | 5.59% | 4.50% | -6.44% | -11.67% | -17.07% |
Pretax Margin | 7.72% | 7.20% | 7.28% | -3.19% | -10.85% | -17.98% |
Profit Margin | 15.03% | 15.95% | 6.67% | -3.39% | -11.00% | -18.01% |
FCF Margin | 13.03% | 8.61% | 11.35% | 0.16% | 0.61% | -10.62% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.77 | 18.43 | 103.82 | - | - | - |
Forward PE | 50.13 | 57.14 | 114.37 | - | - | - |
P/FCF Ratio | 16.79 | 34.15 | 60.96 | 5865.34 | 2942.75 | - |
PS Ratio | 2.19 | 2.94 | 6.92 | 9.61 | 17.84 | 26.97 |